
-
Nanobiotix NASDAQ:NBTX
Location: 60 rue de Wattignies, Ile De France, 75012, France | Website: https://www.nanobiotix.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
160.6M
Cash
66.34M
Avg Qtr Burn
-259.3K
Short % of Float
0.08%
Insider Ownership
0.00%
Institutional Own.
12.79%
Qtr Updated
06/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NBTXR3 +/- Cetuximab Details Head and neck cancer, Cancer | Phase 3 Interim Update | |
JNJ-1900 (NBTXR3) Details Non-small cell lung carcinoma, Cancer | Phase 2 Data readout | |
RT + NBTXR3 + Chemotherapy Details Cancer, Esophageal cancer | Phase 1/2 Data readout | |
RT + NBTXR3 Details Cancer, Pancreatic cancer | Phase 1b Data readout | |
NBTXR3 + Anti-PD-1 Details Head and neck cancer, Cancer, Non-small cell lung carcinoma, Solid tumor/s | Phase 1 Data readout | |
RT + NBTXR3 Details Cancer, Non-small cell lung carcinoma | Phase 1 Data readout |